据悉,CoreWeave此前提出以全股票方式收购Core Scientific,估值约90亿美元。然而,Core Scientific的最大股东Two Seas Capital对此表示强烈反对,认为收购报价"严重低估"了Core Scientific的资产价值。Two Seas Capital还威胁称,如果管理层坚持这一收购计划,他们将发起股东投票反对。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.